Differences between the recently suggested outcome-driven diagnostic threshold of home blood pressure (HBP) measurements and the currently recommended diagnostic threshold of HBP measurements may cause a disagreement between 24-hour ambulatory blood pressure (ABP) and HBP measurements in the diagnosis of hypertension. We evaluated the agreement of various HBP diagnostic thresholds (135/85, 130/85, and 130/80 mm Hg) to ABP measurements, as a reference method.
Original article
Out-of-office blood pressure (BP) measurements have been emphasized because they have the advantage of identifying white-coat and masked hypertension and a stronger predictive power of future cardiovascular risk compared to office BP (OBP) measurements. [1] [2] [3] Among the various types of out-of-office BP measurements, the ambulatory BP (ABP) measurement is recommended as reference method because of its prognostic value and advantage in the detection of white-coat and masked hypertension. 4 The suggested diagnostic threshold of 24-hour ABP measurement is 130 and/or 80 mm Hg; this value was derived from a 10-year population-based study on cardiovascular risk. 5 Home BP (HBP) measurement by automatic device is widely used in the management and diagnosis of
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hypertension because of its convenience and better BP control compared to that of OBP. 6 Moreover, HBP measurement has prognostic value and the advantage of identifying white-coat and masked hypertension over conventional OBP measurement. The currently recommended diagnostic threshold of hypertension by HBP measurements of 135 and/or 85 mm Hg 4 was derived through statistical analysis of a cross-sectional study population by comparing the values of HBP measurements to conventional OBP, and not from outcome-driven studies. 7, 8 Although several studies have shown that HBP measurements may be a reliable alternative to 24-hour ABP measurements, HBP measurements have been debated regarding their suitability as a replacement for 24-hour ABP measurement. 9 Considering recently suggested outcome-driven diagnostic thresholds for HBP measurements (130/85 mm Hg), 10 the disagreement between 24-hour ABP and HBP measurements in the diagnosis of hypertension may be related to the currently recommended diagnostic threshold of HBP measurement of 135/85 mm Hg.
We therefore evaluated the agreement of the various diagnostic thresholds of HBP measurements of 135/85, 130/85, and 130/80 mm Hg to ABP measurements, as a reference method.
METHODS

Study population
Individuals with confirmed high OBP (≥140/90 mm Hg) at the outpatient clinic were referred to 1 of 4 clinical trial centers of participating hospitals (Dongguk University Ilsan Hospital, Inje University Ilsan Paik Hospital, Myongji Hospital, and Seoul Medical Center) from March 2012 to December 2013. Exclusion criteria were as follows: secondary hypertension, hypertensive emergency or urgency, heart failure (New York Heart Association functional class III and VI), clinically significant cardiac arrhythmia, impaired renal function (serum creatinine ≥ 1.7 mg/dl), pregnancy, participating in night labor or shift work, history of abusing drugs or alcohol within 6 months, current participation in other clinical studies, taking other clinical trial drugs within the past month, and taking drugs known to affect BP, such as steroids, monoamine oxidase inhibitors, oral contraceptives, or sympathomimetics. The study protocol and informed consent were reviewed and approved by the Institutional Review Board of each participating hospital. All participants provided written informed consent before entry into the study.
Measurements of OBP, HBP, and 24-hour ABP
The measurement schedule of the study is presented in Figure 1 . During the first visit day, OBP was measured by the study nurse and instruction for taking HBP measurements was given. HBP measurements started from the evening of the first visit day for 7 consecutive days and ended in the morning of the 8th day. Every patient visited on the morning of the 8th day and 24-hour ABP measurement started after obtaining OBP measurements. On the following day, 24-hour ABP measurement ended and OBP was measured. A blood sample for hematologic and biochemical analysis was obtained after at least 8 hours of overnight fasting. OBP measurements were taken from both arms 3 times every visit by the study nurse using a validated oscillometric device (WatchBP Home, Microlife, Taiwan) after 5 minutes of seated rest and at 1-minute intervals.
HBP was measured with the same device used in the measurement of OBP. Participants were instructed to take triplicate measurements at 1-minute intervals every morning (between 07:00 h or waking and 09:00 h) and every evening (between 21:00 h and 23:00 h or bedtime) for 7 consecutive days while seated at a quiet place after 5 minutes of rest. Participants were instructed to obtain the BP measurement in the morning after micturition and before breakfast. A valid measurement was defined as at least 5 days of morning and evening measurements. The first evening and morning BP measurements were discarded, and the first and second reading of the morning and evening were averaged. 11 ABP monitoring over 24 hours was performed on the nondominant arm using an automated, noninvasive oscillometric device (Mobil-O-Graph, I.E.M. GmbH, Germany) with a measurement interval of 30 minutes. Participants were instructed to continue with their normal daily activities during the day. A valid measurement was defined as valid readings for more than 70% of the total measurement attempts, and at least 14 measurements during the daytime (10:00 to 20:00 h) and at least 7 measurements during the nighttime (00:00 to 00:60 h).
Definition of hypertension
Hypertension by ABP measurements was defined as a 24-hour average systolic BP (SBP) ≥130 mm Hg and/or a 24-hour average diastolic BP (DBP) ≥80 mm Hg. 4 Masked hypertension was defined as a normal BP by HBP measurement and hypertension by 24-hour ABP measurement, which is different from the general definition (normal BP by OBP measurement and hypertension by 24-hour ABP measurement). The white-coat hypertension was defined for participants who had elevated HBP according to the 3 different diagnostic thresholds but normal 24-hour ABP measurement.
Statistical analysis
The diagnostic threshold of HBP measurement was evaluated by SBP and DBP alone, and combination of SBP and DBP. In diagnosis of hypertension by HBP measurement, the diagnostic threshold of 130 and 135 mm Hg for SBP and 80 and 85 mm Hg for DBP were applied. The following 3 combinations of SBP and DBP as diagnostic thresholds of hypertension were evaluated: (i) average SBP ≥135 mm Hg and/or average DBP ≥85 mm Hg, (ii) average SBP ≥130 mm Hg and/or average DBP ≥85 mm Hg, and (iii) average SBP ≥130 mm Hg and/or average DBP ≥80 mm Hg.
The linear association between HBP measurement and 24-hour ABP measurement was assessed with linear regression analysis and Pearson's correlation coefficient. A BlandAltman plot was created to calculate the limits of agreement between the 2 methods. The sensitivity, specificity, and positive and negative predictive values of hypertension according to each diagnostic threshold of HBP measurement were calculated using the 24-hour ABP measurement as the reference standard. The degree of overall agreement was determined using Cohen's kappa (κ) coefficient. Overall differences in the proportions across categories of studied variables were analyzed by chi-square tests. When a pair-wise post-hoc analysis among 3 groups was needed, the chi-square test was applied with the Bonferroni-adjusted alpha level.
A P values <0.05 was considered statistically significant.
RESULTS
Of the 319 patients referred to the participating hospitals, 256 were included in the final analysis (22 withdrew their informed consents, 1 took antihypertensive medication, 9 refused 24-hour ABP measurement, 3 refused HBP measurements, 21 were excluded due to invalid data of ABP measurement, and 7 were excluded due to invalid HBP measurement) (Figure 2 ). The clinical characteristics of patients are summarized in Table 1 The diagnostic sensitivity of SBP of HBP measurement was higher for threshold 130 mm Hg than for threshold 135 mm Hg (83.8 vs. 69.6%, P = 0.006). The diagnostic specificity was lower for threshold 130 mm Hg than threshold 135 mm Hg (69.4 vs. 86.1%, P = 0.003). There was a statistical difference in the positive and negative predictive values. The kappa value was not different between threshold 135 mm Hg and 130 mm Hg.
The diagnostic sensitivity of DBP by HBP measurement was higher for threshold 80 mm Hg than for threshold Data are expressed as mean ± SD, or numbers and percent, as appropriate. Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
85 mm Hg (89.3 vs. 74.0%, P < 0.001). The specificity of threshold 85 mm Hg was higher compared to that of threshold 80 mm Hg (P = 0.043).
The diagnostic accuracy of 3 HBP measurement thresholds by combination of SBP and DBP is presented in Table 2 . Among the 3 thresholds, 130/80 mm Hg showed the highest sensitivity (P = 0.001), and lower, but insignificant, specificity compared to those of the other thresholds. The positive and negative predictive value was not different between thresholds, although threshold 130/80 mm Hg showed numerically the highest negative predictive value. Threshold 130/80 mm Hg also showed the highest agreement and kappa value among the 3 thresholds. The diagnosis based on ABP measurement and HBP measurement was consistent in 198 participants (77.3%) with threshold 135/85 mm Hg, 101 (78.9%) with threshold 130/85 mm Hg, and 217 (84.8%) with threshold 130/80 mm Hg. When the diagnostic accuracy of 3 HBP measurement thresholds was analyzed using the daytime and nighttime ABP as the references, threshold 130/80 mm Hg showed the highest sensitivity, agreement, and kappa value among the 3 thresholds (Supplementary Table 1 ).
The prevalence of masked hypertension was lower at the threshold 130/80 mm Hg than at 135/85 mm Hg (P < 0.001, Table 3 ) and 130/85 mm Hg (P = 0.009). Although the prevalence of white-coat hypertension was highest at threshold 130/80 mm Hg, it was not significant compared to that at threshold 135/85 mm Hg (P = 0.132) and 130/85 mm Hg (P = 0.478). When the diagnosis of masked and whitecoat hypertension was defined with daytime and nighttime ABP as the references, threshold 130/80 mm Hg showed the lowest prevalence of masked hypertension and nonsignificant increase in white-coat hypertension (Supplementary Table 2 ).
DISCUSSION
There is a potential for disparity between 24-hour ABP and HBP measurements in the diagnosis of hypertension because of the updated suggested diagnostic threshold of HBP measurements. Herein, we demonstrated that lowering the diagnostic threshold of HBP measurement from 135/85 mm Hg to 130/80 mm Hg may be better for the diagnosis of hypertension by increasing diagnostic sensitivity and lowering the prevalence of masked hypertension. Although the frequency of white-coat hypertension increased at the diagnostic threshold 130/80 mm Hg, the increase was not statistically significant.
Compared to 24-hour ABP measurement, HBP measurement is cheaper, more widely available, and more convenient for patients. The higher practicality of HBP measurement over ABP measurement is widely recognized. 12, 13 Although HBP measurement does not assess BP during sleep or at work, it provides measurements over a longer period. HBP measurement also has the advantage of better prediction of prognosis than OBP measurement and diagnosis of white-coat and masked hypertension. 1, 2, 14, 15 The suggested diagnostic thresholds of HBP measurement by guidelines 4, 11, 15 have been based on meta-analyses, 7, 8 and longitudinal or cohort studies that have attempted to create diagnostic thresholds of HBP measurement in terms of mortality and morbidities. [16] [17] [18] However, HBP measurement has been debated in terms of compatibility with 24-hour ABP measurement, 19, 20 ; in some studies, HBP measurements showed a good agreement with 24-hour ABP measurement for the diagnosis of hypertension, 21, 22 but other studies showed a lack of agreement. 20, 23 Recently, several studies suggested new diagnostic thresholds for hypertension with HBP measurement to improve diagnostic accuracy. 10, 24 In addition to previous reports, our study suggests that lower diagnostic thresholds of HBP measurement than those recommended by guidelines may improve the diagnostic accuracy of hypertension by HBP measurement.
The lower diagnostic threshold in our study may be explained as follows. In our study, the measurement schedule and analysis of measured HBP differed from those of previous studies. Nasothimiou et al. 21 and Kang et al. 20 averaged all HBP without excluding BP measurements on the first day. In addition, the HBP measurement schedule of most studies supporting the currently recommended diagnostic threshold of HBP measurement is different from that in our study and the European Society of Hypertension (ESH) guidelines. The Ohasama study obtained HBP from a single reading in the morning for 1 month but did not utilize multiple measurements or an evening measurement. The Pamela study measured HBP only twice (once in the morning and once in the evening). 17 In our study, hypertension was diagnosed by the averaged HBP values excluding HBP measured on the 1st day. We adopted the measurement schedule recommended by ESH guidelines 11 with a minor modification. Participants started HBP measurement from the evening of the 1st day and the last measurement was performed on the morning of the 8th day morning (7 days of morning measurements and 7 days of evening measurements). We averaged the first 2 of the 3 readings after discarding the evening measurement of the 1st day and morning measurement of the second day. We discarded the morning BP measurement of the second day because it was the first measurement in the morning. The difference in the measurement schedule and the analysis of measured HBP may result in a difference of mean BP. In a study by Stergiou et al., 25 the average HBP measured on the 1st day was significantly higher than that of the other days (from the 2nd day to the 6th day). Moreover, the first reading was consistently higher than the second reading for all measurements on all 6 days. Thus, considering a different measurement schedule, the lower diagnostic threshold of our study may not be surprising. The outcome-driven diagnostic threshold of HBP measurement in the International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) was 130/85 mm Hg. 10 The diagnostic threshold of SBP was the same between our study and that of the IDHOCO study, but our study showed a lower threshold of DBP. Additionally, the differences in the measurement schedule and analysis of measured HBP may not be reflected in the outcome-driven threshold of HBP measurement.
The second explanation for our lower diagnostic threshold is the reference method used for the diagnosis of hypertension. In meta-analyses, the diagnostic threshold was defined through the comparison of HBP measurement to OBP, and not to ABP measurement. 7 ABP measurement has shown to have better prediction of cardiovascular outcome than OBP. [26] [27] [28] [29] The additional advantage of ABP measurement is the detection of white-coat and masked hypertension. 30, 31 Thus, ABP measurement is the preferred method to ensure the accurate measurement of BP and diagnosis and treatment of hypertension. Few studies have evaluated the agreement between HBP measurements and ABP measurement in the diagnosis of hypertension prior to our study. Differently from our study, Nasothimiou et al. showed substantial diagnostic agreement of HBP measurement with ABP measurement. 21 The diagnostic sensitivity, specificity, positive and negative predictive value, and agreement in untreated individuals were 91, 82, 90, 93, and 88%, respectively. However, they diagnosed hypertension as daytime ABP instead of 24-hour ABP. Daytime ABP measurements in the diagnosis of hypertension may miss patients with high nighttime BP. In the study by Kang et al., in which hypertension was diagnosed using 24-hour ABP measurement as the reference method, the diagnostic sensitivity, specificity, positive and negative predictive value, and agreement in untreated patients were 74%, 90%, 87%, 80%, and 83%, respectively. 20 The significance of this study is that, in diagnosing hypertension with HBP measurements, the diagnosis of normal BP using the currently recommended diagnostic criteria may lead to the high frequency of masked hypertension. Although, in general, masked hypertension refers to a patient who is considered hypertensive based on out-of-office BP even when OBP is normal; this study shows that there may be masked hypertension even when the diagnosis of hypertension is made using HBP measurement based on the current diagnostic criteria. There is no study for cardiovascular risk in patients with this type of masked hypertension. However, considering the prognostic significance of 24-hour ABP, the risk of cardiovascular disease is expected to increase if they are misdiagnosed as having normal BP.
There are some limitations of this study. First, the diagnostic threshold of hypertension was compared to the 24-hour ABP measurement as the reference method, and not based on cardiovascular outcomes. It is logical that the diagnostic threshold of hypertension should be based on cardiovascular outcomes. Although outcome-driven diagnostic thresholds of HBP measurements were presented in the IDHOCO study, 10 in which the diagnostic threshold was lower than that of current guidelines, this is also the result of the analysis of data from several cohorts and different HBP measurement methods. In the present study, although the same threshold as that found in the IDHOCO study was not derived, the results were consistent with those of studies suggesting that lowering of the conventional diagnostic thresholds of HBP measurement could improve diagnostic accuracy. Second, the measurement and analysis of HBP were performed differently from previous studies. Differences in the method of HBP measurement and analysis can result in differences in BP values as described above. However, a stricter measurement schedule and analysis such as that in our study may improve the reliability of HBP measurement data. Therefore, long-term follow-up studies with a standardized manner are necessary to establish the diagnostic threshold for hypertension by HBP measurement.
In conclusion, our study showed that lowering the diagnostic thresholds of HBP measurement from 135/85 mm Hg to 130/80 mm Hg may improve diagnostic accuracy for hypertension and is therefore warranted.
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